Skip to main content

State-of-the-Art Facilities

Our facility meets the highest safety standards, ensuring a safe and controlled environment for all manufacturing processes.

Biopharmaceutical
Production Facilities

Our Biosafety Level 2 facility adheres to strict safety protocols, handling biologics and novel modalities with precision. We are Health Canada approved and compliant with US and EMEA FDA regulations, ensuring high standards and market readiness. Utilizing advanced technologies, we support diverse applications, from therapeutics to gene therapy.

Launching Soon

Our Montreal Facility has 7,500L total capacity, with 2 large-scale suites and two backup suites, all with in-suite upstream and downstream processing.

1
Recombinant Subunit Vaccine Suite 3,500L bioreactor capacity BSL2 compliant (can be BSL3 if needed) In-suite upstream and downstream rooms
2
Cell Culture Suite 2,500L bioreactor capacity BSL2 compliant (can be BSL3 if needed) In-suite upstream and downstream rooms
3
Additional Capacity Suite 750L bioreactor capacity BSL1 compliant (can be BSL2/3 if needed) In-suite upstream and downstream rooms
4
Additional Capacity Suite 750L bioreactor capacity BSL1 compliant (can be BSL2/3 if needed) In-suite upstream and downstream rooms

Biosafety Level 2

Our facility operates at Biosafety Level 2, ensuring stringent safety protocols and a controlled environment.

Dedicated Production Areas

Separate Production Areas from Quality Control Labs, Warehouses, and Other Facility Zones

Advanced Manufacturing Technologies

Our advanced capabilities support various applications, including therapeutics, diagnostics, and gene therapy.

Health Canada Approved

We are proud to be Health Canada approved, demonstrating our commitment to meeting high regulatory standards.

US and EMEA FDA Compliant

Our compliance with US and EMEA FDA regulations highlights our dedication to maintaining international standards.